Established in Hangzhou, China, Fanttest Biotech Co., Ltd. is dedicated to the research, development, and production of In-vitro diagnostic reagents. The company was started with a vision to simplify disease detection, make it more affordable, and bring cutting-edge science&technology to everyday diagnosis. Since its founding, we have successfully implemented our strategy of growth through the development and marketing of novel diagnostic tests. The leading products include rapid tests for detection of Infectious Diseases, Sexually Transmitted Diseases, Women’s Health, Respiratory Infection Tests, Digestive Tract Diseases, Drug of Abuse. Our company is ISO 13485:2016, EU IVDD&IVDR, Australian TGA, Brazil ANVASA, and MDSAP certified. The current production capacity is about 1，000，000 tests per day.
TheDuesseldorf Medical Devices Exhibition (MEDICA)is the world’s largest and most authoritative hospital and medical equipment exhibition.It will be held at the Duesseldorf Convention Center from November 13 to 16, 2023.
Hangzhou Fanttest will attend the exhibition at Booth No. 3H19. At the exhibition, we will introduce the advantageous products of our company, including HPV Rapid Test, Novel Coronavirus and Other Respiratory Diseases Combo Rapid Test, FOB Rapid Test Cassette, Candida albicans Rapid Test, Trichomonas Vaginalis Rapid Test, Chlamydia Trachomatis Rapid Test, Multi-Drug Rapid Test (Saliva, Urine), Vitamin D Rapid Test, and so on. Test, Chlamydia Trachomatis Rapid Test, Multi-Drug Rapid Test (Saliva, Urine), Vitamin D Rapid Test, and more!
Looking forward to meeting you at the exhibition.
Post time: Nov-11-2023